# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hatshepsut (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC006-SYN
- Date: 2026-06-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Amunet Okafor-Harrington, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Burning on passing urine and going often for two days. **S**

## History of present illness

Ms. Hatshepsut called this morning and was seen the same day. For two days she has had burning when passing urine, urgency and frequency, with lower abdominal discomfort. She has no fever, chills, back or flank pain, nausea or vomiting, and no vaginal discharge or itching. She has had one bladder infection before, years ago. She is eating and drinking normally. She has taken semaglutide 0.25 mg weekly for four weeks with mild fullness after large meals and is due to step up to 0.5 mg this week. She takes metformin 1000 mg and atorvastatin each evening. Her glucose readings at home have been 110 to 140 mg/dL. Her extraction site has healed. **S**

| Element | Detail |
|---|---|
| Onset | Two days ago |
| Symptoms | Dysuria, urgency, frequency and suprapubic discomfort; no fever or flank pain |
| Context | Type 2 diabetes on metformin and semaglutide; no SGLT2 inhibitor |
| Urine dipstick | Leukocyte esterase and nitrite positive; no blood; glucose negative |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or chills |
| Genitourinary | Positive | Dysuria, urgency and frequency; no blood in the urine; no vaginal discharge |
| Gastrointestinal | Positive | Mild fullness after large meals on semaglutide; no nausea, vomiting or diarrhea |
| Musculoskeletal | Negative | No back or flank pain |

4 systems reviewed. **S**

## Current medications

- Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening meal **S**
- Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed **S**
- Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks) **S**
- Atorvastatin 20 mg oral tablet, one tablet by mouth daily **S**
- Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five days **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/78 mmHg; pulse 84 bpm; respirations 16/min; temperature 37.2 °C; oxygen saturation 98% on room air; weight 90.4 kg; BMI 35.3 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Well; temperature 37.2 °C, pulse 84, blood pressure 122/78 |
| Abdomen | Mild suprapubic tenderness; no other tenderness |
| Back | No costovertebral angle tenderness |
| Mouth | Extraction site healed |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute uncomplicated cystitis** (N30.00). Typical symptoms with a positive dipstick and no fever or flank pain, so this is cystitis, not pyelonephritis. Diabetes raises the risk of urinary infection, and a culture is sent because she has diabetes; with good glucose control and no complicating factor it is treated as uncomplicated. **S**
   - Nitrofurantoin 100 mg twice daily with food for five days.
   - Urine culture sent; the result will be phoned.
   - Plenty of fluids.
   - Return at once for fever, flank pain, vomiting, or no improvement in 48 hours.
2. **Type 2 diabetes during an infection** (E11.65). Home glucose 110 to 140 mg/dL; eating and drinking normally. **S**
   - Continue metformin; pause it if she vomits or cannot keep fluids down, and call.
   - Delay the semaglutide step up to 0.5 mg by one week, to the preventive visit, so that new nausea is not confused with illness.

## Medication changes

- Started: Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five days **S**

## Guideline basis

- Standards of Care in Diabetes—2026 (Section 2, Diagnosis and Classification of Diabetes; Section 9, Pharmacologic Approaches to Glycemic Treatment) (2026), American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S27-S49 and S183-S215)
- International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (2011), Infectious Diseases Society of America (Clin Infect Dis 2011;52(5):e103-e120)

## Follow-up

- Preventive visit in one week as booked; return sooner for any warning sign. **S**
- Next scheduled visit 2026-06-30: periodic adult preventive visit. **S**
